🔎 Trials Near Me

Akèy › Maladi Alzheimer › Florid › Miami

Etid klinik pou Maladi Alzheimer nan Miami, FL

20 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Ap rekriteFaz 2
  • Clinical Site, Miami
  • Clinical Site, Miami
  • Clinical Site, Miami
  • ak 1 plis
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Ap rekriteFaz 2
  • Allied Biomedical Research Institute (ABRI), Inc, Miami
  • South Florida Research Phase I-IV, Miami
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Ap rekriteFaz 3
  • Nuovida Research Center, Miami
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Ap rekriteFaz 4
  • Allied Biomedical Research Institute (ABRI), Inc, Miami
  • CCM Clinical Research Group, LLC, Miami
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470

Combating Alzheimer's Through Sleep and Exercise

Ap rekriteVolontè an sante akeyi
  • University of Miami Hospitals, Miami
Laj 55 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT04855630

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Ap rekriteFaz 2
  • BRP-Kendal Lakes, Miami
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
  • Visionary Investigators Network- Neurology Aventura, Miami
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Ap rekriteFaz 3
  • Miami Jewish health, Miami
  • Local Institution - 2637, Miami
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Ap rekriteFaz 3
  • Local Institution - 1602, Miami
  • Local Institution - 1618, Miami
  • Hope Research Network - Miami, Miami
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011732

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • University of Miami, Miami
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Ap rekriteFaz 3
  • Finlay Medical Research, Miami
  • VIN-Andrew Lerman, Miami
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Ap rekriteFaz 2
  • University of Miami Department of Neurology, Miami
Laj 55 a 90 · Tout sèks · Mizajou May 28, 2026 · NCT06781333

Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Ap rekriteFaz 2
  • University of Miami Department of Neurology, Miami
Laj 55 a 90 · Tout sèks · Mizajou May 28, 2026 · NCT07512362

[18F]PI-2620 Phase 3 Histopathological Study

Ap rekriteFaz 3
  • Miami Jewish Health Systems, Miami
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688

Late Onset Alzheimer's Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of Miami, Miami
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05010603

Open-label Extension Study in Participants With Early Alzheimer's Disease

Ap rekriteFaz 2
  • GSK Investigational Site, Miami
Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Ap rekrite
  • Baptist Health South Florida & Florida International University, Miami
Laj 50 a 85 · Tout sèks · Mizajou Jan 9, 2026 · NCT03671889

Longitudinal Cognitive Assessment by BoCA

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Andrey Vyshedskiy, Miami
Laj 50 ak plis · Tout sèks · Mizajou Aug 1, 2024 · NCT04114994

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Andrey Vyshedskiy, Miami
Laj 50 ak plis · Tout sèks · Mizajou Aug 1, 2024 · NCT03657745

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.